Clearside Biomedical (CLSD) Appoints Tony Gibney as Board Chair
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
November 4, 2024 7:05 AM ESTALPHARETTA, Ga., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today the appointment of Tony Gibney as Chair of its Board of Directors, effective November 1, 2024. Mr. Gibney, who joined Clearsides Board as an independent director in April 2024, succeeds Clay Thorp, who will continue serving as a member of the Board.
George Lasezkay, PharmD, JD, President and Chief Executive Officer, Clearside Biomedical, commented, Tony is a highly respected... More
